Primary driver of growth is the escalating incidences Hormone Imbalance Disorders among the Neonatal and Geriatric Populations.

Global Hormone Replacement Therapy Market

Dublin, December 26, 2022 (GLOBE NEWSWIRE — The “Hormone Replacement Therapy Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027” Report has been added ResearchAndMarkets.com’s offering.

In 2021, the global market for hormone replacement therapy was worth US$ 8.1 billion. The market is expected to grow at 6.02% per year in 2021-2027 according to the publisher.

We are constantly monitoring and evaluating the pandemic’s direct and indirect effects, keeping in mind the uncertainties surrounding COVID-19. These insights are included as a key market contributor in the report.

The hormone replacement therapy (HRT), is used to replenish low levels of hormones in the body. This therapy is especially beneficial for people with growth hormone deficiencies, women in their twenties and those suffering from hypogonadism. HRT can be done in many forms, such as transdermal skin and mouth patches, gels or injections.

HRT is not recommended for patients with untreated high blood pressure, liver disease, blood clots or other health issues. The therapy can also cause nausea, bloating, swelling, headaches, leg cramps and leg cramps.

Market growth is being driven principally by an increase in the prevalence of hormone imbalance disorders among the geriatric population and the neonatal population. Hormone replacement therapy (HRT), which is a hormone replacement therapy, is seeing a rise in demand due to the need for safer treatments.

These therapies are also attractive because of the aggressive marketing campaigns and direct selling campaigns carried out by key players. The market is also being driven by increasing awareness and regularly monitored formulations.

Competitive Landscape

The report has also analysed the competitive landscape of the market with some of the key players being Abbott Laboratories, Bayer AG, Eli Lilly & Company, Roche, Hisamitsu Pharmaceutical Co. Inc., Merck, Mylan, Novartis, Novo Nordisk and Pfizer.

This Report Answers Key Questions
1. What is the outlook for the global market for hormone replacement therapy in the forecast period (2022-2027).
2. What are the key market drivers for hormone replacement therapy?
3. What are the key trends in the global market hormone replacement therapy market
4. How does COVID-19 impact the global market for hormone replacement therapy?
5. What is the market size for hormone replacement therapy in the world, broken down by product type?
6. What is the breakdown of the global hormone replacement therapy market by route of administration
7. What is the breakdown of the global hormone replacement therapy market by type?
8. Which are the main regions of the global market for hormone replacement therapy?

We cover the following key topics:

1 Preface

2 Scope and Methodology

3 Executive Summary

4 Introduction
4.1 Overview
4.2 Key Industry Trends

Five Global Hormone Replacement Therapy Markets
5.1 Market Overview
5.2 Market Performance
5.3 The Impact of COVID-19
5.4 Price Analysis
5.5 Market breakdown by product
5.6 Market Disintegration by Route of Administration
5.7 Market Split by Type of Disease
5.8 Market Splitup by Region
5.9 Market Outlook
5.10 SWOT Analysis
5.11 Value Chain Analysis
5.12 Porters Five Forces Analysis

6 Market Breakdown by Product
6.1 Estrogen Replacement Therapy
6.1.1 Market Trends
6.1.2 Market Forecast
6.2 Replacement Therapy for Human Growth Hormone
6.2.1 Market Trends
6.2.2 Market Forecast
6.3 Thyroid Replacement Therapy
6.3.1 Market Trends
6.3.2 Market Outlook
6.4 Testosterone Replacement Therapy
6.4.1 Market Trends
6.4.2 Market Outlook
6.5 Other
6.5.1 Market Trends
6.5.2 Market Forecast

7 Markets Broken Up by Route of Administration
7.1 Oral
7.1.1 Market Trends
7.1.2 Market Forecast
7.2 Parenteral
7.2.1 Market Trends
7.2.2 Market Forecast
7.3 Transdermal
7.3.1 Market Trends
7.3.2 Market Outlook

8 Market Breakups by Type of Disease
8.1 Menopause
8.1.1 Market Trends
8.1.2 Market Outlook
8.2 Hypothyroidism
8.2.1 Market Trends
8.2.2 Market Forecast
8.3 Male Hypogonadism
8.3.1 Market Trends
8.3.2 Market Outlook
8.4 Growth Hormone Deficiency
8.4.1 Market Trends
8.4.2 Market Forecast
8.8 Others
8.5.1 Market Trends
8.5.2 Market Forecast

9 Market Breakups by Region

Ten Competitive Landscapes
10.1 Market Structure
10.2 Key Players
10.3 Profiles of key players
10.3.1 Abbott Laboratories
10.3.2 Bayer AG
10.3.3 Eli Lilly & Company
10.3.4 Roche
10.3.5 Hisamitsu Pharmaceutical Co. Inc.
10.3.6 Merck
10.3.7 Mylan NV
10.3.8 Novartis AG
10.3.9 Novo Nordisk A/S
10.3.10 Pfizer Inc.

This report has more information, visit https://www.researchandmarkets.com/r/6hw6xh

Attachment

CONTACT: CONTACT: ResearchAndMarkets.com Laura Wood,Senior Press Manager [email protected] For E.S.T Office Hours Call 1-917-300-0470 For U.S./ CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900